Combining MCMC with 'sequential' PKPD modelling

被引:66
作者
Lunn, David [3 ]
Best, Nicky [4 ]
Spiegelhalter, David [3 ]
Graham, Gordon [1 ]
Neuenschwander, Beat [2 ]
机构
[1] Pfizer Ltd, Sandwich, Kent, England
[2] Novartis Pharma AG, Basel, Switzerland
[3] Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 0SR, England
[4] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England
基金
英国医学研究理事会;
关键词
Feedback; Graphical models; Markov chain Monte Carlo; Sequential PKPD; WinBUGS; POPULATION; PHARMACOKINETICS; DISTRIBUTIONS;
D O I
10.1007/s10928-008-9109-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We introduce a method for preventing unwanted feedback in Bayesian PKPD link models. We illustrate the approach using a simple example on a single individual, and subsequently demonstrate the ease with which it can be applied to more general settings. In particular, we look at the three 'sequential' population PKPD models examined by Zhang et al. (J Pharmacokinet Pharmacodyn 30:387-404, 2003; J Pharmacokinet Pharmacodyn 30:405-416, 2003), and provide graphical representations of these models to elucidate their structure. An important feature of our approach is that it allows uncertainty regarding the PK parameters to propagate through to inferences on the PD parameters. This is in contrast to standard two-stage approaches whereby 'plug-in' point estimates for either the population or the individual-specific PK parameters are required.
引用
收藏
页码:19 / 38
页数:20
相关论文
共 25 条
[1]   A POPULATION ANALYSIS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MIDAZOLAM IN THE RAT [J].
AARONS, L ;
MANDEMA, JW ;
DANHOF, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (05) :485-496
[2]  
Beal S.L., 1992, NONMEM USERS GUIDE 1
[3]   Estimation of population pharmacokinetics using the Gibbs sampler [J].
Best, NG ;
Tan, KKC ;
Gilks, WR ;
Spiegelhalter, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (04) :407-435
[4]  
Dempster AP, 1997, STAT COMPUT, V7, P247, DOI 10.1023/A:1018598421607
[5]   SAMPLING-BASED APPROACHES TO CALCULATING MARGINAL DENSITIES [J].
GELFAND, AE ;
SMITH, AFM .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1990, 85 (410) :398-409
[6]   STOCHASTIC RELAXATION, GIBBS DISTRIBUTIONS, AND THE BAYESIAN RESTORATION OF IMAGES [J].
GEMAN, S ;
GEMAN, D .
IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE, 1984, 6 (06) :721-741
[7]   Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data [J].
Graham, G ;
Gupta, S ;
Aarons, L .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2002, 29 (01) :67-88
[8]   Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs [J].
Gueorguieva, Ivelina ;
Aarons, Leon ;
Rowland, Malcolm .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (05) :571-594
[9]  
HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97
[10]   INDEPENDENCE PROPERTIES OF DIRECTED MARKOV-FIELDS [J].
LAURITZEN, SL ;
DAWID, AP ;
LARSEN, BN ;
LEIMER, HG .
NETWORKS, 1990, 20 (05) :491-505